WORLD
CANCER DAY -
WE CARE

1. THE COOLED RFA TECHNOLOGY

IT'S PREDICTABLE

  • Create large-volume lesions without excessive heating at the active tip1
  • Minimizes potential for char with internally cooled ablation probe2
  • Thermocouple monitors tissue temperature around the distal tip of the probe


OsteoCool™ RF ablation is for the palliative treatment of spinal metastases with cooled radiofrequency ablation technology.
It lets you treat patients confidently and consistently with reproducible precision3.

 

2. THE SYNERGY WITH RADIOTHERAPY

IMPROVED PAIN RESPONSE

Di Staso, et al, showed that patients who received radiofrequency ablation (RFA) in conjunction with RT, vs. RT alone, for bone metastases palliation received:4*

6 WEEKS

Faster pain response

33%
INCREASE

in overall pain
response p = 0.048

PARTNERING

TO ELEVATE

THE STANDARD

OF CARE


Radiation therapy (RT) is the gold standard palliative treatment for patients with bone metastases. But there may be patients who cannot or do not benefit from RT as the only treatment for pain palliation.

3. THE STREAMLINED PROCEDURE

COMBINE THE SOLUTIONS

Combining OsteoCool™ RF ablation and Kyphon™ Balloon Kyphoplasty (BKP) allows you to predictably ablate the lesion and stabilise the fractured bone during the same procedure5. Provide your patients reliable therapy options in one streamlined procedure.

pdf YOUR EXPERTISE AND OUR INNOVATIONS (.pdf)

Treat painful spinal metastases and stabilize
the fractured bone using the same access and instruments.

7.5MB

Contact Medtronic for More Information

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

View our privacy statement

RFA therapy used: Leveen Needle Electrode (Boston Scientific Corp.)

1

Medtronic Internal data - Engineering Test Reports #31100966, #31100961

2

Medtronic Internal data - Engineering Test Report #31100966

3

Internal bench Medtronic Internal data - Engineering Test Report #31100966

4

Di Staso M, Zugaro L, Gravina GL, et al. A feasibility study of percutaneous radiofrequency ablation followed by radiotherapy in the management of painful osteolytic bone metastases. Eur Radiol. 2011;21(9):2004-2010. doi: 10.1007/s00330-011-2133-3. Epub 2011 May 1.

5

Wardlaw D et al. Lancet 2009; 373: 1016-1024

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.eu.

michelson technology